• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同方法制备的难溶性他达拉非无定形固体分散体的溶出机制及释放动力学研究

Investigation of Dissolution Mechanism and Release Kinetics of Poorly Water-Soluble Tadalafil from Amorphous Solid Dispersions Prepared by Various Methods.

作者信息

Školáková Tereza, Slámová Michaela, Školáková Andrea, Kadeřábková Alena, Patera Jan, Zámostný Petr

机构信息

Department of Organic Technology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.

Department of Metals and Corrosion Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.

出版信息

Pharmaceutics. 2019 Aug 2;11(8):383. doi: 10.3390/pharmaceutics11080383.

DOI:10.3390/pharmaceutics11080383
PMID:31382377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6722951/
Abstract

The aims of this study were to investigate how the release of tadalafil is influenced by two grades of polyvinylpyrrolidone (Kollidon 12 PF and Kollidon VA 64) and various methods of preparing solid dispersions (solvent evaporation, spray drying and hot-melt extrusion). Tadalafil is poorly water-soluble and its high melting point makes it very sensitive to the solid dispersion preparation method. Therefore, the objectives were to make a comparative evaluation among different solid dispersions and to assess the effect of the physicochemical nature of solid dispersions on the drug release profile with respect to the erosion-diffusion mechanism. The solid dispersions were evaluated for dissolution profiles, XRD, SEM, FT-IR, DSC, and solubility or stability studies. It was found that tadalafil release was influenced by polymer molecular weight. Therefore, solid dispersions containing Kollidon 12 PF showed a faster dissolution rate compared to Kollidon VA 64. Tadalafil was released from solid dispersions containing Kollidon 12 PF because of the combination of erosion and diffusion mechanisms. The diffusion mechanisms were predominant in the initial phase of the experiment and the slow erosion was dissolution-controlling at the second stage of the dissolution. On the contrary, the tadalafil release rate from solid dispersions containing Kollidon VA 64 was controlled solely by the erosion mechanism.

摘要

本研究的目的是探究两种聚乙烯吡咯烷酮(聚乙烯吡咯烷酮12 PF和聚乙烯吡咯烷酮VA 64)以及各种制备固体分散体的方法(溶剂蒸发法、喷雾干燥法和热熔挤出法)如何影响他达拉非的释放。他达拉非的水溶性较差,且其高熔点使其对固体分散体制备方法非常敏感。因此,目标是对不同的固体分散体进行比较评估,并根据溶蚀-扩散机制评估固体分散体的物理化学性质对药物释放曲线的影响。对固体分散体进行了溶出曲线、X射线衍射(XRD)、扫描电子显微镜(SEM)、傅里叶变换红外光谱(FT-IR)、差示扫描量热法(DSC)以及溶解度或稳定性研究。结果发现,他达拉非的释放受聚合物分子量的影响。因此,与聚乙烯吡咯烷酮VA 64相比,含有聚乙烯吡咯烷酮12 PF的固体分散体显示出更快的溶出速率。他达拉非从含有聚乙烯吡咯烷酮12 PF的固体分散体中释放是由于溶蚀和扩散机制的共同作用。在实验的初始阶段,扩散机制占主导,而在溶出的第二阶段,缓慢的溶蚀是溶出控制因素。相反,含有聚乙烯吡咯烷酮VA 64的固体分散体中他达拉非的释放速率仅受溶蚀机制控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/429f244bc7ba/pharmaceutics-11-00383-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/0f2c66f7ab41/pharmaceutics-11-00383-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/96796f8be42f/pharmaceutics-11-00383-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/f209a8785437/pharmaceutics-11-00383-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/ea3f1d96e73c/pharmaceutics-11-00383-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/4e85e4b879e7/pharmaceutics-11-00383-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/5ad136c09594/pharmaceutics-11-00383-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/51fcae4e7a68/pharmaceutics-11-00383-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/58d889802da6/pharmaceutics-11-00383-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/5736920fdcd0/pharmaceutics-11-00383-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/9c277c09cec7/pharmaceutics-11-00383-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/ac0067e3361c/pharmaceutics-11-00383-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/362c75fd60be/pharmaceutics-11-00383-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/d2de2a11b892/pharmaceutics-11-00383-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/a1703ed9ed4a/pharmaceutics-11-00383-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/c1afbf7c3e03/pharmaceutics-11-00383-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/69888e0442af/pharmaceutics-11-00383-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/429f244bc7ba/pharmaceutics-11-00383-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/0f2c66f7ab41/pharmaceutics-11-00383-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/96796f8be42f/pharmaceutics-11-00383-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/f209a8785437/pharmaceutics-11-00383-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/ea3f1d96e73c/pharmaceutics-11-00383-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/4e85e4b879e7/pharmaceutics-11-00383-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/5ad136c09594/pharmaceutics-11-00383-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/51fcae4e7a68/pharmaceutics-11-00383-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/58d889802da6/pharmaceutics-11-00383-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/5736920fdcd0/pharmaceutics-11-00383-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/9c277c09cec7/pharmaceutics-11-00383-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/ac0067e3361c/pharmaceutics-11-00383-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/362c75fd60be/pharmaceutics-11-00383-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/d2de2a11b892/pharmaceutics-11-00383-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/a1703ed9ed4a/pharmaceutics-11-00383-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/c1afbf7c3e03/pharmaceutics-11-00383-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/69888e0442af/pharmaceutics-11-00383-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad0d/6722951/429f244bc7ba/pharmaceutics-11-00383-g014.jpg

相似文献

1
Investigation of Dissolution Mechanism and Release Kinetics of Poorly Water-Soluble Tadalafil from Amorphous Solid Dispersions Prepared by Various Methods.不同方法制备的难溶性他达拉非无定形固体分散体的溶出机制及释放动力学研究
Pharmaceutics. 2019 Aug 2;11(8):383. doi: 10.3390/pharmaceutics11080383.
2
Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.他达拉非固体分散体的物理化学性质——聚合物对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Biopharm. 2015 Aug;94:106-15. doi: 10.1016/j.ejpb.2015.04.031. Epub 2015 May 19.
3
How to Improve Solubility and Dissolution of Irbesartan by Fabricating Ternary Solid Dispersions: Optimization and In-Vitro Characterization.通过制备三元固体分散体提高厄贝沙坦的溶解度和溶出度:优化与体外表征
Pharmaceutics. 2022 Oct 23;14(11):2264. doi: 10.3390/pharmaceutics14112264.
4
Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.他达拉非在PVP-VA中的喷雾干燥和球磨固体分散体的直接压片的物理化学性质
Eur J Pharm Biopharm. 2016 Dec;109:14-23. doi: 10.1016/j.ejpb.2016.09.011. Epub 2016 Sep 20.
5
Investigation of tadalafil molecular arrangement in solid dispersions using inverse gas chromatography and Raman mapping.采用反气相色谱和拉曼映射研究他达拉非固体分散体中的分子排列。
Int J Pharm. 2022 Jul 25;623:121955. doi: 10.1016/j.ijpharm.2022.121955. Epub 2022 Jun 24.
6
Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.热熔挤出法与喷雾干燥法:热熔挤出法会使阿苯达唑降解。
Drug Dev Ind Pharm. 2017 May;43(5):797-811. doi: 10.1080/03639045.2016.1220577. Epub 2016 Oct 20.
7
Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats.用于制备他达拉非固体分散体的亲水性聚合物的应用:微尺度性质、释放度和雄性大鼠勃起功能障碍研究。
PeerJ. 2022 May 26;10:e13482. doi: 10.7717/peerj.13482. eCollection 2022.
8
Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion.表面积归一化溶出度研究喷雾干燥和热熔挤出法制备的伊曲康唑-共聚维酮固体分散体的差异。
Int J Pharm. 2018 Apr 5;540(1-2):106-119. doi: 10.1016/j.ijpharm.2018.02.005. Epub 2018 Feb 7.
9
Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.评价聚合物载体对热熔挤出法制备的双芬酸盐固体分散体生物利用度增强的影响。
Drug Dev Ind Pharm. 2012 Jun;38(6):735-43. doi: 10.3109/03639045.2011.623703. Epub 2011 Oct 15.
10
Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.通过抗溶剂沉淀法提高他达拉非纳米粒子的表观溶解度和生物利用度。
Eur J Pharm Sci. 2019 Feb 1;128:222-231. doi: 10.1016/j.ejps.2018.12.005. Epub 2018 Dec 13.

引用本文的文献

1
Twin Screw Melt Granulation of Simvastatin: Drug Solubility and Dissolution Rate Enhancement Using Polymer Blends.辛伐他汀的双螺杆熔融制粒:使用聚合物共混物提高药物溶解度和溶出速率
Pharmaceutics. 2024 Dec 23;16(12):1630. doi: 10.3390/pharmaceutics16121630.
2
Exploring Orodispersible Films Containing the Proteolysis Targeting Chimera ARV-110 in Hot Melt Extrusion and Solvent Casting Using Polyvinyl Alcohol.探索使用聚乙烯醇通过热熔挤出和溶剂浇铸法制备的含蛋白酶靶向嵌合体ARV-110的口腔崩解膜。
Pharmaceutics. 2024 Nov 22;16(12):1499. doi: 10.3390/pharmaceutics16121499.
3
Preparation, Characterization and Evaluation of Nintedanib Amorphous Solid Dispersions with Enhanced Oral Bioavailability.

本文引用的文献

1
Bioenhanced advanced third generation solid dispersion of tadalafil: Repurposing with improved therapy in pyelonephritis.他达拉非的生物增强型先进第三代固体分散体:在肾盂肾炎中重新利用以改善治疗效果。
Asian J Pharm Sci. 2017 Nov;12(6):569-579. doi: 10.1016/j.ajps.2017.07.001. Epub 2017 Aug 3.
2
Tailoring supersaturation from amorphous solid dispersions.从无定形固体分散体中定制过饱和度。
J Control Release. 2018 Jun 10;279:114-125. doi: 10.1016/j.jconrel.2018.04.014. Epub 2018 Apr 11.
3
Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
制备、表征和评价具有增强口服生物利用度的尼达尼布无定形固体分散体。
AAPS PharmSciTech. 2024 Aug 13;25(6):183. doi: 10.1208/s12249-024-02902-x.
4
A Fisetin Delivery System for Neuroprotection: A Co-Amorphous Dispersion Prepared in Supercritical Carbon Dioxide.一种用于神经保护的漆黄素递送系统:在超临界二氧化碳中制备的共无定形分散体。
Antioxidants (Basel). 2023 Dec 21;13(1):24. doi: 10.3390/antiox13010024.
5
Development of an Image-based Method for Tablet Microstructure Description and Its Correlation with API Release Rate.基于图像的片剂微观结构描述方法的开发及其与 API 释放率的相关性。
AAPS PharmSciTech. 2023 Oct 2;24(7):199. doi: 10.1208/s12249-023-02658-w.
6
Comparative analysis of drug-salt-polymer interactions by experiment and molecular simulation improves biopharmaceutical performance.通过实验和分子模拟对药物-盐-聚合物相互作用进行比较分析可改善生物制药性能。
Commun Chem. 2023 Sep 25;6(1):201. doi: 10.1038/s42004-023-01006-0.
7
Amorphous System of Hesperetin and Piperine-Improvement of Apparent Solubility, Permeability, and Biological Activities.橙皮素和胡椒碱无定形系统:提高表观溶解度、渗透性和生物活性。
Int J Mol Sci. 2023 Mar 2;24(5):4859. doi: 10.3390/ijms24054859.
8
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACs.用于克服PROTACs口服给药障碍的溶解度增强制剂方法。
Pharmaceutics. 2023 Jan 3;15(1):156. doi: 10.3390/pharmaceutics15010156.
9
Sustained-Release Solid Dispersion of High-Melting-Point and Insoluble Resveratrol Prepared through Hot Melt Extrusion to Improve Its Solubility and Bioavailability.采用热熔挤出技术制备高熔点难溶性白藜芦醇的固体分散体以提高其溶解度和生物利用度
Molecules. 2021 Aug 17;26(16):4982. doi: 10.3390/molecules26164982.
10
Selective Laser Sintering of Solid Oral Dosage Forms with Copovidone and Paracetamol Using a CO Laser.使用CO激光对含共聚维酮和对乙酰氨基酚的固体口服剂型进行选择性激光烧结
Pharmaceutics. 2021 Jan 26;13(2):160. doi: 10.3390/pharmaceutics13020160.
考察环氧乙烷-环氧丙烷共聚物对热熔挤出固体分散体增溶的作用。
J Pharm Sci. 2018 May;107(5):1372-1382. doi: 10.1016/j.xphs.2018.01.016. Epub 2018 Feb 1.
4
Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs.喷雾干燥法提高难溶性药物生物利用度的最新策略。
J Control Release. 2018 Jan 10;269:110-127. doi: 10.1016/j.jconrel.2017.11.005. Epub 2017 Nov 5.
5
Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats.基于 PVP/VA S-630 的他达拉非固体分散体配方:提高大鼠的口服生物利用度。
Eur J Pharm Sci. 2017 Aug 30;106:152-158. doi: 10.1016/j.ejps.2017.05.065. Epub 2017 Jun 1.
6
In vitro and in vivo behavior of ground tadalafil hot-melt extrudates: How the carrier material can effectively assure rapid or controlled drug release.他达拉非研磨热熔挤出物的体外和体内行为:载体材料如何有效确保药物快速或可控释放。
Int J Pharm. 2017 Aug 7;528(1-2):498-510. doi: 10.1016/j.ijpharm.2017.05.057. Epub 2017 May 27.
7
Use of acidifier and solubilizer in tadalafil solid dispersion to enhance the in vitro dissolution and oral bioavailability in rats.他达拉非固体分散体中酸化剂和增溶剂的使用以提高大鼠体外溶出度和口服生物利用度。
Int J Pharm. 2017 Jun 30;526(1-2):77-87. doi: 10.1016/j.ijpharm.2017.04.056. Epub 2017 Apr 24.
8
Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate.基于PVP/VA S-630的他达拉非固体分散体设计以提高溶出速率。
Eur J Pharm Sci. 2017 Jan 15;97:269-276. doi: 10.1016/j.ejps.2016.11.030. Epub 2016 Dec 2.
9
Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.他达拉非在PVP-VA中的喷雾干燥和球磨固体分散体的直接压片的物理化学性质
Eur J Pharm Biopharm. 2016 Dec;109:14-23. doi: 10.1016/j.ejpb.2016.09.011. Epub 2016 Sep 20.
10
High energy ball milling and supercritical carbon dioxide impregnation as co-processing methods to improve dissolution of tadalafil.高能球磨法和超临界二氧化碳浸渍法作为共处理方法以改善他达拉非的溶出度。
Eur J Pharm Sci. 2016 Dec 1;95:130-137. doi: 10.1016/j.ejps.2016.05.007. Epub 2016 May 7.